Workflow
Logic
icon
Search documents
Viewbix Announces Pricing of $4.5 Million Private Placement Priced At-The-Market under Nasdaq Rules
Globenewswire· 2025-07-11 13:05
Tel Aviv, Israel, July 11, 2025 (GLOBE NEWSWIRE) -- Viewbix Inc. (Nasdaq: VBIX) (“Viewbix” or the “Company”), a global developer of ad-tech innovative technologies, today announced that it has entered into definitive agreements with certain strategic institutional investors for the purchase and sale of approximately $4.5 million shares of the Company’s common stock and pre-funded warrants. The entire transaction has been priced at-the-market under Nasdaq rules. Following the transaction, the Company plans t ...
3 AI-Driven Medical Device Stocks to Watch in 2025
ZACKS· 2025-07-11 13:01
Key Takeaways BSX uses AI in diagnostics, imaging, and mapping systems to improve cardiac procedure outcomes. JNJ integrates AI into robotic platforms and digital ecosystems for advanced surgical analytics. GEHC leads in FDA-cleared AI devices and enhances imaging with tools like CleaRecon DL and ABUS Premium.Globally, generative artificial intelligence (Gen AI) and agentic AI are increasingly being integrated into medical devices, transforming both clinical workflows and patient care. Gen AI is primarily ...
重磅!骨科巨头推出便携式骨愈合设备
思宇MedTech· 2025-07-10 10:13
2025年7月7日, Enovis Corporation (NYSE: ENOV) 宣布推出 Manafuse ® 骨生长刺激器 ,这是一款便携 式、电池供电的医疗设备,采用 低强度脉冲超声(LIPUS)技术 ,用于非侵入性治疗新鲜骨折和骨折不愈 合。 # Manafuse ® 骨生长刺激器 Manafuse ® 骨生长刺激器 通过发射LIPUS信号,激活人体自身的愈合过程,从而加速骨折愈合 。其配备非 无菌换能器、固定带和凝胶,需由医疗专业人员使用放射影像或解剖标记确认正确放置位置,并用不可擦除标 记在患者皮肤上标记应用部位。具有以下主要特点: 适用于治疗 特定新鲜骨折 (如闭合的、后移位远端桡骨骨折和闭合或I级开放胫骨骨干骨折)以及 骨折不愈 合 (排除颅骨和椎骨)。设备需在骨科医生通过闭合复位和石膏固定进行骨折管理时使用。 便携性和易用性 :Manafuse是便携式设备,电池供电,患者每天 仅需使用20分钟 , 最长可使用343 天 ,适合家庭使用,可穿戴于石膏、支具或衣物之上。 LIPUS技术 :通过发射低强度脉冲超声信号,刺激骨细胞(成骨细胞)分裂和生长,激活身体的自然愈 合过程。LIPUS技术已 ...
高盛:华虹半导体_管理层电话会议_满负荷利用率支撑价格走势;尽管有折旧与摊销负担,毛利率仍有望改善;评级中性
Goldman Sachs· 2025-07-09 02:40
7 July 2025 | 3:27PM HKT Hua Hong (1347.HK): Mgmt. Call: Full UT rate to support pricing trend; GM improvements ahead despite D&A burdens; Neutral We hosted Hua Hong management on July 7 in our China Semis Corp Call series (July 7 - 10). Key discussions were around pricing strategies, UT rates, the company's capacity expansion plans and outlook on margin levels. Overall, Hua Hong remains positive on their operations, with UT rates of its major fabs at 100% or above, supported by a strong demand across power ...
以玩促学?游戏代码驱动数据合成,提升多模态大模型通用推理
机器之心· 2025-07-04 08:59
如果告诉你, AI 在推箱子等游戏场景上训练,能让它在几何推理与图表推理上表现更好,你会相信 吗? 复旦 NLP 实验室联合字节跳动智能服务团队的最新研究给出了一个令人意外的发现: 游戏不仅是娱乐 工具,更是训练 AI 推理能力的宝贵资源。 Code2Logic: Game-Code-Driven Data Synthesis for Enhancing VLMs General Reasoning 论文链接: https://arxiv.org/abs/2505.13886 代码仓库: https://github.com/tongjingqi/Code2Logic 标题: 数据和模型: https://huggingface.co/Code2Logic 引言 高质量多模态推理数据的极度稀缺,制约了视觉语言模型( VLMs )复杂推理能力的提升。那么,有 没有一种低成本又可靠的方法来大规模生成这些数据呢? 复旦与字节的研究团队创新性地提出了一个巧妙的思路: 利用游戏代码自动合成视觉推理数据。 | A | ਟ | E | ч | 0 | - | | --- | --- | --- | --- | --- | ...
Oruka Therapeutics Announces Promotion of Laura Sandler to Chief Operating Officer
GlobeNewswire News Room· 2025-07-01 20:01
MENLO PARK, Calif., July 01, 2025 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc. (“Oruka”) (Nasdaq: ORKA), a clinical-stage biotechnology company developing novel biologics designed to set a new standard for the treatment of chronic skin diseases including plaque psoriasis (PsO), today announced the promotion of Laura Sandler to Chief Operating Officer. Ms. Sandler, who joined Oruka in 2024 as SVP of Operations, brings over 20 years of biopharmaceutical leadership experience across clinical operations, develo ...
Teva Releases Q2 2025 Aide Memoire
Globenewswire· 2025-06-26 20:30
TEL AVIV, Israel, June 26, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that its Q2 2025 Aide Memoire is available on the “Investors” page on its website. Q2 2025 Aide Memoire Teva has prepared this document to assist in the financial modeling of its quarterly results. The document is based on Teva’s prior results, management’s previous commentary about Teva’s business outlook and data from select independent sources. About Teva Teva Pharmaceutical Indus ...
CIEN, Telxius Hit a Pioneering 1.3 Tb/s Wavelength Across the Atlantic
ZACKS· 2025-06-26 15:06
Key Takeaways CIEN and Telxius set a record 1.3 Tb/s single-wavelength transmission on the Marea cable. CIEN's WL6e tech delivers 1.6 Tb/s capacity with 50% lower power and space per bit. CIEN added 24 new WL6e customers in Q2, reaching 49 just two quarters after launch.Ciena Corporation (CIEN) recently partnered with Telxius, a leading international connectivity provider, to achieve the industry’s first 1.3 terabit-per-second (Tb/s) single-wavelength optical transmission across the 6,600-km Marea submari ...
Maravai LifeSciences Appoints Rajesh Asarpota as Chief Financial Officer
Globenewswire· 2025-06-25 20:01
SAN DIEGO, June 25, 2025 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced that Rajesh “Raj” Asarpota has been appointed Executive Vice President (EVP) and Chief Financial Officer (CFO), effective June 30, 2025. He will succeed Kevin Herde, who is transitioning to an advisory role on the same date to support an effective transition. “We thank Kevin for his commitment to Marav ...
Globant: Overly Penalized, But Growth Remains Solid
Seeking Alpha· 2025-06-24 18:35
Company Overview - Globant is an Argentine technology company operating in 36 countries and providing a multitude of technological services worldwide [1] - The company has 31,100 employees, with the United States and Canada being its main sources of revenue, representing 55% of its income [1] Market Position - Globant's operations are significantly focused on North America, which is crucial for its revenue generation [1]